Taiwan: Hemp

  |   Attaché Report (GAIN)   |   TW2021-0033

Taiwan does not have a market for hemp products because cannabis is classified as a Class 2 narcotic. All drugs or products that contain tetrahydrocannabinol (THC) over 10ug/g (10ppm) are in the same class of narcotics. Taiwan’s Food and Drug Administration specifies that drugs containing cannabidiol (CBD) are allowed, but there are currently no domestic approved drugs with CBD content and there is no rule or law allowing for the sale of CBD related products and drugs in Taiwan. Therefore, Taiwan currently has very little to no potential for importing hemp or hemp related products.

Related Reports

Attaché Report (GAIN)

United Kingdom: Sustainable Aviation Fuel in the UK

As part of a broad push towards reducing carbon emissions in the aviation sector, the newly elected Labour government is seeking to bolster the United Kingdom’s (UK) Sustainable Aviation Fuel (SAF) industry, which builds on initiatives and policies...
On October 30, the Department for Business and Trade (DBT) extended over 220 voluntary tariff suspensions announced following the 2021 and 2023 application periods, through June 30, 2026. The announcement synchronizes multiple expiration periods...
The European Commission will allocate €132 million (approximately $138 million) towards promotion activities for EU agri-food products in 2025.